SNDX · Syndax Pharmaceuticals Inc
$19.84
+0.76 (+3.98%)
At close · Aug 14
Market Cap
$1.77B
Shares
89.30M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-04 | 2026-06-30 | |
| 8-K | 2026-08-04 | — | |
| 8-K | 2026-07-14 | — | |
| 8-K | 2026-06-10 | — | |
| 8-K | 2026-06-10 | — | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 8-K | 2026-04-30 | — | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| DEF 14A | 2026-04-30 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-19 | 2025-12-18 | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-24 | — | |
| 10-Q | 2025-08-04 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-06-26 | 2025-06-24 | |
| 8-K | 2025-05-16 | 2025-05-12 | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| DEF 14A | 2025-04-01 | — | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2024-12-20 | — | |
| 8-K | 2024-11-18 | 2024-11-15 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-11-05 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-02 | 2024-03-27 | |
| 8-K | 2024-03-18 | 2024-03-15 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2023-12-20 | 2023-12-19 | |
| 8-K | 2023-12-15 | 2023-12-14 | |
| 8-K | 2023-12-12 | 2023-12-10 | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-10-02 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-07-24 | — | |
| 8-K | 2023-05-26 | — |
Showing 1–50 of 112 filings
Key facts
CIK
1395937
CUSIP
87164F105
13F (30d)
233 filings
227 filers
Visit website
Investor relations